TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 141 resultados LastUpdate Última actualización 17/08/2019 [17:08:00] pdf PDF

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days

Página1 de 6 nextPage   por página


ELECTRONIC DEVICE AND METHOD FOR CONTROLLING SAME

NºPublicación: US2019246991A1 15/08/2019

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

KR_20180043612_A

Resumen de: US2019246991A1

Provided are an electronic device and a method for controlling the same. An electronic device for providing continuous blood glucose monitoring comprises: a first sensor for measuring a glucose level of an interstitial fluid in order to predict blood glucose; a second sensor disposed on an inner surface of the electronic device to be in contact with a human body, in order to measure at least one of a blood flow and a heart rate of the human body; and a processor for determining a diffusion time during which glucose present in blood diffuses into the interstitial fluid, on the basis of characteristics of a signal generated by the second sensor, and predicting the blood glucose on the basis of the glucose level measured by the first sensor and the determined diffusion time.

traducir

Medical Infusion Pump System

NºPublicación: US2019247568A1 15/08/2019

Solicitante:

THATCHER MICHAEL GEORGE [US]

Resumen de: US2019247568A1

A medical infusion pump system is disclosed. The medical infusion pump system is a multi-reservoir infusion device for dispensing at least compositions of insulin and an amylin analog for treatment of subjects. Insulin and the amylin analog are stored in separate reservoirs, each reservoir being operatively connected to a motor for providing discharge pressure to the reservoirs. The motors may act independently such that insulin and the amylin analog may be injected at incongruent times. The medical infusion pump may automatically dispense the amylin analog into a subject's blood once the subject's blood-glucose levels rise above a specific threshold, or may dispense the amylin analog based on expected levels of blood glucose.

traducir

Combined Non Invasive Blood Glucose Monitor Device

NºPublicación: US2019246964A1 15/08/2019

Solicitante:

ZHANG MICHAEL [CA]
WU ZHENYU [CA]

Resumen de: US2019246964A1

This patent is a combined non-invasive method of monitoring glucose level. Monitoring the concentration of glucose level in human blood and tissue was developed by a combined non-invasive technique. This combined method includes skin temperature and pulse wave measurement. All these measurements are used to calculate the blood glucose level. This method also can be used to measure the diabetes related damage of micro arterial.

traducir

SENSOR SYSTEMS, DEVICES, AND METHODS FOR CONTINUOUS GLUCOSE MONITORING

NºPublicación: US2019246961A1 15/08/2019

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2017181673_PA

Resumen de: US2019246961A1

Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms.

traducir

SYSTEM AND METHOD FOR DECISION SUPPORT

NºPublicación: US2019246973A1 15/08/2019

Solicitante:

DEXCOM INC [US]

US_2019246914_A1

Resumen de: US2019246973A1

Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration level. The glucose concentration level may be provided to a stored model to determine a state. The guidance may be determined based at least in part on the determined state.

traducir

IN-VIVO ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY (EIS)-BASED CALIBRATION

NºPublicación: US2019246943A1 15/08/2019

Solicitante:

MEDTRONIC MINIMED INC [US]

CN_110037713_A

Resumen de: US2019246943A1

Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.

traducir

SENSOR SYSTEMS, DEVICES, AND METHODS FOR CONTINUOUS GLUCOSE MONITORING

NºPublicación: US2019246960A1 15/08/2019

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2017181672_PA

Resumen de: US2019246960A1

Electrochemical impedance spectroscopy (EIS) may be used in conjunction with continuous glucose monitoring (CGM) to enable identification of valid and reliable sensor data, as well implementation of Smart Calibration algorithms.

traducir

MULTI-ANALYTE CONTINUOUS GLUCOSE MONITORING

NºPublicación: US2019246962A1 15/08/2019

Solicitante:

PERCUSENSE INC [US]

Resumen de: US2019246962A1

A system to automatically detect at least one physiological state is disclosed. The system includes a single probe for insertion within a subject that has an analyte sensor array for continuous monitoring of at least glucose and a second analyte. The system further includes an electronics module that includes a power supply, a processor, memory and a bi-directional communications module. When the electronics module is coupled with the analyte sensor array the power supply delivers power to the analyte sensor array and the processor. The processor analyzing glucose and the second analyte data to detect a first physiological state from a plurality of physiological states.

traducir

SYSTEM AND METHOD FOR DECISION SUPPORT

NºPublicación: US2019246914A1 15/08/2019

Solicitante:

DEXCOM INC [US]

US_2019246973_A1

Resumen de: US2019246914A1

Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration level. The glucose concentration level may be provided to a stored model to determine a state. The guidance may be determined based at least in part on the determined state.

traducir

SYSTEM AND METHOD FOR DECISION SUPPORT

NºPublicación: US2019252079A1 15/08/2019

Solicitante:

DEXCOM INC [US]

US_2019246914_A1

Resumen de: US2019252079A1

Systems and methods are provided to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a patient glucose concentration data sensed by a glucose concentration sensor. A host state change associated with the host glucose concentration data may be determined. A guidance message based at least in part on the host state change may also be determined. The guidance message may be delivered through a user interface.

traducir

TISSUE IMPLANTABLE SENSOR WITH HERMETICALLY SEALED HOUSING

NºPublicación: US2019246957A1 15/08/2019

Solicitante:

GLYSENS INCORPORATED [US]

CN_103826528_A

Resumen de: US2019246957A1

A tissue-implantable sensor for measurement of solutes in fluids and gases, such as oxygen and glucose, is provided. The sensor includes: i) a detector array including at least one detector; ii) a telemetry transmission portal; iii) an electrical power source; and iv) circuitry electrically connected to the detector array including signal processing means for determining an analyte level, such as glucose level, in a body fluid contacting the detectors. The sensor components are disposed in a hermetically sealed housing having a size and shape suitable for comfortable, safe, and unobtrusive subcutaneous implantation allowing for in vivo detection and long term monitoring of tissue glucose concentrations by wireless telemetry.

traducir

ANALYTE SENSOR

NºPublicación: US2019246965A1 15/08/2019

Solicitante:

DEXCOM INC [US]

US_2019076071_A1

Resumen de: US2019246965A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

traducir

ADJUSTING INSULIN DELIVERY RATES

NºPublicación: US2019247578A1 15/08/2019

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

JP_2019509074_A

Resumen de: US2019247578A1

A method may include generating a first plurality of insulin delivery profiles that include a first series of insulin delivery actions spanning a first time interval, projecting a first plurality of future blood glucose values for each profile of the first plurality of profiles using up-to-date blood glucose levels, selecting one of the first plurality of profiles based upon comparing future blood glucose values for each profile and target blood glucose levels, delivering insulin for a second time interval that corresponds to a first action of the first profile, generating a second plurality of insulin delivery profiles for a third time interval, projecting a second plurality of future blood glucose values for each profile of the second plurality of profiles for the third time interval, and delivering a second dose of insulin for a fourth time interval shorter than the third time interval.

traducir

Measurement of susceptibility to diabetic foot ulcers

NºPublicación: GB2571014A 14/08/2019

Solicitante:

BRUIN BIOMETRICS LLC [US]

KR_20190084956_A

Resumen de: GB2571014A

The present disclosure provides apparatuses and methods for measuring capacitance as an indication of susceptibility to the formation of a diabetic foot ulcer.

traducir

Multi-stream data collection system for noninvasive measurement of blood constituents

NºPublicación: US10376190B1 13/08/2019

Solicitante:

MASIMO CORP [US]

US_10376191_B1

Resumen de: US10376190B1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

Multi-stream data collection system for noninvasive measurement of blood constituents

NºPublicación: US10376191B1 13/08/2019

Solicitante:

MASIMO CORP [US]

US_10376190_B1

Resumen de: US10376191B1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

GLUCOSE SENSOR ELECTRODE DESIGN

NºPublicación: US2019239778A1 08/08/2019

Solicitante:

MEDTRONIC MINIMED INC [US]

Resumen de: US2019239778A1

A single flex double-sided electrode useful in a continuous glucose monitoring sensor. In one example, a counter electrode is placed on the back-side of the flex and a work electrode is placed on the top-side of the sensor flex. The electrode is fabricated on physical vapor deposited metal deposited on a base substrate. Adhesion of the electrode to the base substrate is carefully controlled so that the electrode can be processed on the substrate and subsequently removed from the substrate after processing.

traducir

DIVERSIFIED GLUCOSE SENSOR SYSTEM

NºPublicación: US2019239779A1 08/08/2019

Solicitante:

CHASE ARNOLD [US]

Resumen de: US2019239779A1

A diversified glucose sensor system comprises an introducer needle and two or more independent sensor bodies, each sensor body having one or more sensing elements that can be subcutaneously positioned in a patient's body by insertion of the introducer needle for glucose measurement. The system further includes a progressive insertion device comprising an insertion shaft that pushes the sensor bodies out the end opening of the introducer needle to a desired depth in the patient prior to removal of the insertion shaft and the introducer needle. The sensor bodies are bent or folded and held under stress within the introducer needle for insertion, and released and biased outwardly when pushed out of the introducer needle. The sensing elements are anchored and disposed within the patient at positions providing X/Y/Z-axis diversity for measurement.

traducir

COMPOSITION FOR TREATMENT OF INFERTILITY IN A FEMALE SUBJECT

NºPublicación: US2019240338A1 08/08/2019

Solicitante:

ISIFER AB [SE]

Resumen de: US2019240338A1

A pharmaceutical composition for treating infertility in a female subject substantially consists of local anesthetic of amide type such as lidocaine, human albumin, viscosity controlling agent selected from recombinant hyaluronic acid and combination of recombinant hyaluronic acid and water-soluble cellulose ether, optionally citrate, glucose, and/or amino acid, water optionally comprising one or more ions selected from the group consisting of sodium, potassium, magnesium, calcium, acetate, chloride, sulfate. Also disclosed is a method of treating infertility by administration of the composition to a female subject in need thereof.

traducir

DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS

NºPublicación: US2019239782A1 08/08/2019

Solicitante:

DEXCOM INC [US]

US_2018192926_A1

Resumen de: US2019239782A1

Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.

traducir

USER INTERFACES FOR CONTINUOUS GLUCOSE MONITORING

NºPublicación: US2019239745A1 08/08/2019

Solicitante:

DEXCOM INC [US]

US_2019223721_A1

Resumen de: US2019239745A1

The subject matter disclosed herein provides methods for presenting glucose level data. Glucose data for a patient may be received. A current glucose level and a rate of change of the current glucose level may be determined based on the received glucose data. A first interface may be displayed on a screen of a device. The first interface may include a unitary icon. The unitary icon may display the current glucose level and a visualization of the rate of change. Related apparatus, systems, techniques, and articles are also described.

traducir

MULTILAYER ELECTROCHEMICAL ANALYTE SENSORS AND METHODS FOR MAKING AND USING THEM

NºPublicación: US2019241926A1 08/08/2019

Solicitante:

MEDTRONIC MINIMED INC [US]

Resumen de: US2019241926A1

Embodiments of the invention provide multilayer analyte sensors having material layers (e.g. high-density amine layers) and/or configurations of material layers that function to enhance sensor function, as well as methods for making and using such sensors. Typical embodiments of the invention include glucose sensors used in the management of diabetes.

traducir

METHOD FOR EMPHASIZING ANALYTE VALUES DURING A THERAPEUTIC WINDOW

NºPublicación: US2019239780A1 08/08/2019

Solicitante:

ROCHE DIABETES CARE INC [US]

CN_109890268_A

Resumen de: US2019239780A1

In diabetes management applications, recent glucose measurement values may be clinically useful for acute diagnosis and for the calculation of a corrective therapy. However, the physiological significance of these measurements can lessen with time, which can lead to their becoming less relevant for calculating an effective therapy. A technique is presented for emphasizing analyte values in a diabetes management application during a therapeutic window. In this way, a user is notified that the glucose measurement value is the most current measurement and remains usable for therapy applications, such as an insulin bolus calculation.

traducir

DEVICES, METHODS, AND SYSTEMS FOR THE TREATMENT AND/OR MONITORING OF DAMAGED TISSUE

NºPublicación: US2019240475A1 08/08/2019

Solicitante:

ADLORE INC [US]

Resumen de: US2019240475A1

Disclosed are methods, devices, and systems for treatment of an abnormal wound healing response. The methods, devices, and systems can be used to treat solid ulcerated tissue, such as diabetic foot ulcers (DFUs), arthritic tissue, muscle soreness, joint pain, varicose veins, obesity, and peripheral artery disease. Additionally, the methods, devices, and systems can promote the healing of xenograft, allograft, autograft, or engineered tissue following reconstruction surgery. The methods, devices, and systems include the ability to determine an optimal set of pulse parameters that are specific to wound healing. In embodiments, the methods, devices, and systems include components for guiding the user on electrode placement based on anatomical or electrical measurements, delivering a custom series of electric pulses, applying heat, and using feedback from physiologic measurements to control the device.

traducir

SYSTEMS AND METHODS FOR ESTIMATING THE RISK OF A FUTRUE HYPOGLYCEMIC EVENT

Nº publicación: US2019244713A1 08/08/2019

Solicitante:

NOVO NORDISK AS [DK]

CN_109863563_A

Resumen de: US2019244713A1

A device (250) for estimating the risk of a future hypoglycemic event for a subject with a standing insulin regimen (206), wherein the standing insulin regimen comprises one or more types of insulin medicament dosage regimen (208), wherein each of the one or more types of insulin medicament dosage regimen (208) comprises a type of insulin medicament (210) defining one or more types of insulin medicaments. Using the evaluation of a glucose concentration, a first time derivative and an insulin on board for the subject in a current metabolic state, and the evaluation of a glucose concentration, a first derivative and a historical insulin on board to estimate a hypoglycemic risk measure.

traducir

Página1 de 6 nextPage por página

punteroimgVolver